Clinical trial
Efficacy of Gynodian® Depot in Women With Impaired Well-being
NCT00463450 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00463450 |
|---|---|
| Title | Efficacy of Gynodian® Depot in Women With Impaired Well-being |
| Official title | A Multicenter, Double-blind, Randomized, Cross-over Study to Investigate the Efficacy of Gynodian® Depot i.m. Compared to 4 mg Estradiol Valerate i.m. Both Given Every Four Weeks for Five Months Combined With 5 mg Medroxyprogesterone Acetate Orally in Postmeno-pausal Women With Impaired Well-being… |
| Lead sponsor | Bayer, Industry |
| Collaborators | Navitas Life Sciences GmbH Industry LKF Laboratory |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hormone Replacement Therapy |
| Intervention type | Drug |
| Interventions | Gynodian® Depot (BAY86-5032), BAY86-4980 |
| Enrollment | 140 |
| Start date | May 1, 2002 |
| Completion | Apr 1, 2004 |
| First posted | Apr 20, 2007 |
| Last update posted | Dec 30, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: